TCM
SYRE icon

Tang Capital Management’s Spyre Therapeutics SYRE Stock Holding History

Tang Capital Management’s Portfolio SYRE Stock Details SYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$47.9M Buy
3,200,000
+1,150,000
+56% +$17.2M 2.42% 9
2025
Q1 		$33.1M Buy
+2,050,000
New +$33.1M 1.83% 12